Cambrian

We are building medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.

[Cambrian @CambrianBio]

Happening today ‼️

@TheEndoSociety

[James Peyer @JamesPeyer]

This weekend I'm headed to the @TheEndoSociety conference in SF where we've been invited to give an oral presentation.

I’ll be sharing with the world for the first time the ability of our lead drug, ATX-304 to 🧵👇

[Cambrian @CambrianBio]

This Sunday, 7/13‼️Our CEO @JamesPeyer is headed to @TheEndoSociety to present new data on the efficacy of ATX-304, our lead drug. Check out the press release to learn more 👇

https://t.co/dykERwYSwT

[James Peyer @JamesPeyer]

One of the most hollow critiques of translating discoveries about aging biology – “they will only be for the rich.”

Demand curve says no. Preventative medicines are cheaper than other drugs and these will be among the best preventatives of all time.
https://t.co/KGeOLdukKE

[James Peyer @JamesPeyer]

This newsletter is meant to be my own thinking and I try to be a bit more provocative here, so the views I express might not always reflect the position of @CambrianBio, which is much larger than me alone.
https://t.co/DTJWKjxwXM

[Cambrian @CambrianBio]

You can learn more about the historical disparities of women’s health on the @OvivaTx website. While you're there, be sure to explore the incredible work they're doing to improve women’s health through groundbreaking biomedical research! https://t.co/d3Ds4Ekahg

[Cambrian @CambrianBio]

Happy International Women’s day! Here are some fun facts about women’s health 👇

[Cambrian @CambrianBio]

But today, as we celebrate women and the progress made, let's remember that our work isn't done. We must continue pushing for a future where women's health is prioritized, ensuring that every woman receives the care she deserves.

[Cambrian @CambrianBio]

While we don't endorse chasing people down for snacks, our goal is to enable everyone to live as Dyna-Mitally through later years! 😉 #DinamitaDinero

[Cambrian @CambrianBio]

Awesome news from our friends at @bioagelabs, congratulations!

[BioAge @bioagelabs]

BioAge is pleased to announce our $170M Series D financing to advance our therapies for obesity & metabolic diseases. The round was led by Sofinnova, with top-tier healthcare investors including key obesity strategics Lilly & Amgen.

https://t.co/btG4yv7pRD

(🧵 1/8)

[Cambrian @CambrianBio]

To learn more about ATX-304 check out this blog by James: https://t.co/fTQMJEdYl2

[Cambrian @CambrianBio]

Do you consider the potential impact of medical interventions on individuals' motivation to make difficult lifestyle changes, particularly in cases such as #obesity, where lifestyle changes are challenging but essential for improving health outcomes? 👇

[Cambrian @CambrianBio]

Check out the full interview for free here: https://t.co/oxSq0bVRLa

[Cambrian @CambrianBio]

This news is incredibly disheartening for the entire field and those personally impacted by her. We can only aspire, as a community, to build on the foundation she was instrumental in fortifying. May she rest in peace.

[Cambrian @CambrianBio]

It is with great sadness that we share that this week we learned about the passing of Judith Campisi, who was, amongst many other wonderful things, a pioneer in the aging space. (Cont.) https://t.co/zf6It91ah1

[Cambrian @CambrianBio]

She gained widespread recognition for her extensive research on the impact of senescent cells on aging and cancer. Despite facing numerous challenges, she dedicated years to the pursuit of this research, and the data she generated is now acclaimed as a hallmark of aging. (Cont.)

[Cambrian @CambrianBio]

Check out the full article for a deeper understanding of these complexities, as well as for some insights from leaders in the space. https://t.co/YBT48CzxgZ

[Cambrian @CambrianBio]

“Nobody would argue that we shouldn’t develop therapies for Alzheimer’s or cancer because these diseases are a natural part of getting older. So, why would this argument hold for aging?” 🧵

[Cambrian @CambrianBio]

(including #mTOR inhibitors, such as those pursued by our pipeline company, Tornado Therapeutics). The article also explores barriers to progress and issues a cautionary note about the 'hype' surrounding less scientifically rigorous aspects of our field.